A detailed history of International Assets Investment Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 880,939 shares of REGN stock, worth $650 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
880,939
Previous 1,023 86013.29%
Holding current value
$650 Million
Previous $1.08 Billion 99.92%
% of portfolio
0.0%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$1024.09 - $1201.76 $901 Million - $1.06 Billion
879,916 Added 86013.29%
880,939 $838,000
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $253,478 - $307,431
287 Added 38.99%
1,023 $1.08 Billion
Q1 2024

Apr 11, 2024

BUY
$902.69 - $993.35 $56,869 - $62,581
63 Added 9.36%
736 $713 Million
Q4 2023

Jan 25, 2024

SELL
$775.18 - $881.7 $458 Million - $521 Million
-590,416 Reduced 99.89%
673 $591,000
Q4 2023

Jan 24, 2024

BUY
$775.18 - $881.7 $458 Million - $520 Million
590,314 Added 76169.55%
591,089 $673,000
Q3 2023

Oct 04, 2023

SELL
$692.45 - $844.37 $20,081 - $24,486
-29 Reduced 3.61%
775 $637,000
Q2 2023

Jul 20, 2023

BUY
$700.03 - $830.35 $40,601 - $48,160
58 Added 7.77%
804 $577,000
Q1 2023

Apr 19, 2023

SELL
$680.49 - $826.97 $10.2 Million - $12.4 Million
-15,019 Reduced 95.27%
746 $612,000
Q4 2022

Jan 30, 2023

BUY
$705.89 - $766.39 $11.1 Million - $12.1 Million
15,744 Added 74971.43%
15,765 $11.4 Million
Q4 2022

Jan 24, 2023

SELL
$705.89 - $766.39 $201,178 - $218,421
-285 Reduced 93.14%
21 $0
Q3 2022

Oct 31, 2022

BUY
$573.97 - $724.32 $175,634 - $221,641
306 New
306 $211,000
Q2 2021

Jul 14, 2021

SELL
$472.8 - $558.54 $206,140 - $243,523
-436 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$446.73 - $548.2 $103,194 - $126,634
231 Added 112.68%
436 $208,000
Q4 2020

Jan 22, 2021

BUY
$478.3 - $607.98 $98,051 - $124,635
205 New
205 $99 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.